We are live on
!
Find out more
FA
FCG Advisors Portfolio holdings
AUM
$425M
1-Year Est. Return
12.09%
This Fund
S&P 500
This Quarter
Est. Return
-0.18%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
–
AUM
$123M
AUM Growth
–
Cap. Flow
+$124M
Cap. Flow
% of AUM
100.88%
Top 10 Holdings %
Top 10 Hldgs %
59.43%
Holding
65
New
65
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$33.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$6.78M |
| 3 |
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
|
+$6.38M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$5.84M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$4.91M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 27.09% |
| 2 | Technology | 4.7% |
| 3 | Industrials | 4.1% |
| 4 | Financials | 4.02% |
| 5 | Energy | 1.51% |
Similar funds
LWS
VCP
CCM
AIM
MGAI
CPF
IA
F
FCG Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for FCG Advisors, which disclosed 65 positions worth $123M. Its ten largest holdings account for 59% of the portfolio.
Its largest position is Celgene Corp: 549,778 shares worth $32.2M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, followed by Technology and Industrials.
- FCG Advisors's largest Q2 2013 buy was Celgene Corp: 549,778 shares worth $32.2M.
- FCG Advisors's ten largest holdings make up 59% of its $123M portfolio in Q2 2013.
- FCG Advisors disclosed 65 positions in Q2 2013, its first 13F filing on record.
Based on FCG Advisors's 13F filing for Q2 2013, filed 12 Aug 2013.